Fibrin sealant topical Pregnancy and Breastfeeding Warnings
Medically reviewed by Drugs.com. Last updated on Aug 1, 2023.
Fibrin sealant topical Pregnancy Warnings
Fibrin sealant topical has been assigned to pregnancy category C by the FDA. Animal reproduction studies have not been conducted with fibrin sealant topical. There are no controlled data in human pregnancy. Fibrin sealant topical should be given during pregnancy when need has been clearly established.
It is not known whether fibrin sealant topical can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.
Fibrin sealant topical Breastfeeding Warnings
There are no data on the excretion of fibrin sealant topical into human milk. Because many drugs are excreted in human milk, caution is recommended when fibrin sealant topical is administered to a lactating woman.
See also
References for pregnancy information
- (2008) "Product Information. Tisseel (fibrin sealant topical)." Baxter Healthcare Corporation
References for breastfeeding information
- (2008) "Product Information. Tisseel (fibrin sealant topical)." Baxter Healthcare Corporation
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.